199 related articles for article (PubMed ID: 16256784)
1. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting.
Butterworth J; Wagenknecht LE; Legault C; Zaccaro DJ; Kon ND; Hammon JW; Rogers AT; Troost BT; Stump DA; Furberg CD; Coker LH
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1319. PubMed ID: 16256784
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery.
Knapik P; Nadziakiewicz P; Urbanska E; Saucha W; Herdynska M; Zembala M
Ann Thorac Surg; 2009 Jun; 87(6):1859-65. PubMed ID: 19463610
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
[TBL] [Abstract][Full Text] [Related]
4. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
Quinn DW; Pagano D; Bonser RS; Rooney SJ; Graham TR; Wilson IC; Keogh BE; Townend JN; Lewis ME; Nightingale P;
J Thorac Cardiovasc Surg; 2006 Jan; 131(1):34-42. PubMed ID: 16399292
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
[TBL] [Abstract][Full Text] [Related]
6. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery.
Cywinski JB; Koch CG; Krajewski LP; Smedira N; Li L; Starr NJ
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):796-802. PubMed ID: 17138083
[TBL] [Abstract][Full Text] [Related]
7. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.
Furnary AP; Gao G; Grunkemeier GL; Wu Y; Zerr KJ; Bookin SO; Floten HS; Starr A
J Thorac Cardiovasc Surg; 2003 May; 125(5):1007-21. PubMed ID: 12771873
[TBL] [Abstract][Full Text] [Related]
8. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial.
Bilotta F; Spinelli A; Giovannini F; Doronzio A; Delfini R; Rosa G
J Neurosurg Anesthesiol; 2007 Jul; 19(3):156-60. PubMed ID: 17592345
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery.
Jones KW; Cain AS; Mitchell JH; Millar RC; Rimmasch HL; French TK; Abbate SL; Roberts CA; Stevenson SR; Marshall D; Lappé DL
J Diabetes Complications; 2008; 22(6):365-70. PubMed ID: 18413193
[TBL] [Abstract][Full Text] [Related]
10. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
[TBL] [Abstract][Full Text] [Related]
11. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery.
Anderson RE; Brismar K; Barr G; Ivert T
Eur J Cardiothorac Surg; 2005 Sep; 28(3):425-30. PubMed ID: 16054822
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
[TBL] [Abstract][Full Text] [Related]
13. Centrifugal versus roller head pumps for cardiopulmonary bypass: effect on early neuropsychologic outcomes after coronary artery surgery.
Scott DA; Silbert BS; Doyle TJ; Blyth C; Borton MC; O'brien JL; de L Horne DJ
J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):715-22. PubMed ID: 12486652
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
Ulas MM; Hizarci M; Kunt A; Ergun K; Kocabeyoglu SS; Korkmaz K; Lafci G; Gedik S; Cagli K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):518-23. PubMed ID: 19034033
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].
Hoedemaekers CW; Pickkers P; Netea MG; van Deuren M; Van der Hoeven JG
Crit Care; 2005; 9(6):R790-7. PubMed ID: 16356228
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychologic and quality-of-life outcomes after coronary artery bypass surgery with and without cardiopulmonary bypass: a prospective randomized trial.
Tully PJ; Baker RA; Kneebone AC; Knight JL
J Cardiothorac Vasc Anesth; 2008 Aug; 22(4):515-21. PubMed ID: 18662624
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass.
Stamou SC; Hill PC; Haile E; Prince S; Mack MJ; Corso PJ
J Thorac Cardiovasc Surg; 2006 Jan; 131(1):28-33. PubMed ID: 16399291
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery bypass grafting with single cross-clamp results in fewer persistent neuropsychological deficits than multiple clamp or off-pump coronary artery bypass grafting.
Hammon JW; Stump DA; Butterworth JF; Moody DM; Rorie K; Deal DD; Kincaid EH; Oaks TE; Kon ND
Ann Thorac Surg; 2007 Oct; 84(4):1174-8; discussion 1178-9. PubMed ID: 17888966
[TBL] [Abstract][Full Text] [Related]
19. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure.
Charlson ME; Peterson JC; Krieger KH; Hartman GS; Hollenberg JP; Briggs WM; Segal AZ; Parikh M; Thomas SJ; Donahue RG; Purcell MH; Pirraglia PA; Isom OW
J Card Surg; 2007; 22(6):465-72. PubMed ID: 18039205
[TBL] [Abstract][Full Text] [Related]
20. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction?
Qiu ZB; Chen X; Xu M; Shi KH; Jiang YS; Xiao LQ
Chin Med J (Engl); 2008 Dec; 121(23):2397-402. PubMed ID: 19102956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
